Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Matias-Guiu, X; Garrastazu, MT

    Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIa

    Histopathology 32 281-282. .

  • Chivite, A; Matias-Guiu, X; Pons, C; Algaba, F; Prat, J

    Inhibin a expression in adrenal neoplasms - a new immunohistochemical marker for adrenocortical tumors

    APPL IMMUNOHISTO M M 6 42-49. .

    [doi:10.1097/00022744-199803000-00008]

  • Matias-Guiu, X; Garcia, A; Curell, R; Prat, J

    Renal cell carcinoma metastatic to the thyroid gland: a comparative molecular study between the primary and the metastatic tumor

    ENDOCRINE PATHOLOGY 9 255-260. .

    [doi:10.1007/BF02739966]

  • Matias-Guiu, J; Sempere, AP; Diaz-Marin, C; Beltran, I

    The contents of the neurological publications

    REVISTA DE NEUROLOGIA 25 2088-2088. .

  • MATIASGUIU, X; Lerma, E; Prat, J

    Clear cell tumors of the female genital tract

    SEMINARS IN DIAGNOSTIC PATHOLOGY 14 233-239. .

  • Pujol, RM; MATIASGUIU, X; Miralles, J; Colomer, A; deMoragas, JM

    Multiple idiopathic mucosal neuromas: a minor form of multiple endocrine neoplasia type 2B or a new entity?

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 37 349-352. .

    [doi:10.1016/S0190-9622(97)70025-2]

  • LaGuette, J; MATIASGUIU, X; Rosai, J

    Thyroid paraganglioma: a clinicopathologic and immunohistochemical study of three cases

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 21 748-753. .

    [doi:10.1097/00000478-199707000-00002]

  • MATIASGUIU, X; LaGuette, J; PurasGil, AM; Rosai, J

    Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 21 754-762. .

    [doi:10.1097/00000478-199707000-00003]

  • Berna, LI; Flotats, A; PuigDomingo, M; Piera, J; MATIASGUIU, X; Caixas, A; Estorch, M; Catafau, A; Mari, C; Carrio, I

    Tc-99m-MIBI in the localization of parathyroid abnormal glands in patients presenting with primary hyperparathyroidism.

    Journal Of Nuclear Medicine 38 609-609. .

  • Berna, LI; Mari, C; Chico, A; Piera, J; MATIASGUIU, X; Alonso, C; Flotats, A; Estorch, M; Catafau, A; Carrio, I

    In-111-octreotide in the localization of recurrent medullary thyroid carcinoma.

    Journal Of Nuclear Medicine 38 613-613. .

  • Cuatrecasas, M; Villanueva, A; MATIASGUIU, X; Prat, J

    K-ras mutations in mucinous ovarian tumors - a clinicopathologic and molecular study of 95 cases

    CANCER 79 1581-1586. .

    [doi:10.1002/(SICI)1097-0142(19970415)79:8<1581::AID-CNCR21>3.0.CO;2-T]

  • Garcia, A; MATIASGUIU, X; Cabezas, R; Chico, A; Prat, J; Baiget, M; DeLeiva, A

    Molecular diagnosis of von Hippel-Lindau disease in a kindred with a predominance of familial phaeochromocytoma

    CLINICAL ENDOCRINOLOGY 46 359-363. .

    [doi:10.1046/j.1365-2265.1997.00149.x]

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU